Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa

被引：0
|
作者：
Luisa Sorlí
Sonia Luque
Concepción Segura
Nuria Campillo
Milagro Montero
Erika Esteve
Sabina Herrera
Natividad Benito
Francisco Alvarez-Lerma
Santiago Grau
Juan Pablo Horcajada
机构：
[1] Infectious Disease Service,InfectiousDiseaseUnit, Department of Internal Medicine
[2] Hospital del Mar,undefined
[3] Pharmacy Service,undefined
[4] Hospital del Mar,undefined
[5] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),undefined
[6] Laboratori de Referència de Catalunya,undefined
[7] Hospital de la Santa Creu i Sant Pau,undefined
[8] Institut d’Investigació Biomèdica Sant Pau,undefined
[9] Spanish Network for Research in Infectious Diseases (REIPI RD12/0015),undefined
[10] Instituto de Salud Carlos III,undefined
[11] Intensive Care Unit,undefined
[12] Hospital del Mar,undefined
[13] CIBERES,undefined
[14] Universitat Autònoma de Barcelona,undefined
[15] CEXS-Universitat Pompeu Fabra,undefined
来源：
BMC Infectious Diseases | / 17卷
关键词：
Colistin; Mortality; Plasma concentration; Extremely drug-resistant; Nephrotoxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
    Sorli, Luisa
    Luque, Sonia
    Segura, Concepcion
    Campillo, Nuria
    Montero, Milagro
    Esteve, Erika
    Herrera, Sabina
    Benito, Natividad
    Alvarez-Lerma, Francisco
    Grau, Santiago
    Pablo Horcajada, Juan
    BMC INFECTIOUS DISEASES, 2017, 17
  • [2] Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa
    Sorli, Luisa
    Luque, Sonia
    Li, Jian
    Benitez-Cano, Adela
    Fernandez, Xenia
    Prim, Nuria
    Vega, Victoria
    Gomez-Junyent, Joan
    Lopez-Montesinos, Inmaculada
    Gomez-Zorrilla, Silvia
    Montero, M. Milagro
    Grau, Santiago
    Horcajada, Juan Pablo
    MICROBIOLOGY SPECTRUM, 2023,
  • [3] Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical
    Sorli, Luisa
    Luque, Sonia
    Li, Jian
    Campillo, Nuria
    Danes, Marc
    Montero, Milagro
    Segura, Concha
    Grau, Santiago
    Pablo Horcajada, Juan
    JOURNAL OF INFECTION, 2019, 79 (03) : 253 - 261
  • [4] Use of topical colistin in bacterial keratitis caused by extensively drug-resistant Pseudomonas Aeruginosa: a case report
    Maticorena-Quevedo, Jesus
    Patino-Valderrama, Lia
    Arellano-Caro, Karin
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2023, 86 (04) : 384 - 387
  • [5] Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients
    Hachem, Ray Y.
    Chemaly, Roy F.
    Ahmar, Corine A.
    Jiang, Ying
    Boktour, Maha R.
    Abou Rjaili, Georges
    Bodey, Gerald P.
    Raad, Issam I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1905 - 1911
  • [6] Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients
    Mauri, MC
    Volonteri, LS
    Fiorentini, A
    Invernizzi, G
    Nerini, T
    Baldi, M
    Bareggi, SR
    SCHIZOPHRENIA RESEARCH, 2004, 66 (2-3) : 197 - 198
  • [7] Use of Topical Colistin in Multiple Drug-Resistant Pseudomonas aeruginosa Bacterial Keratitis
    Jain, Rajat
    Murthy, Somasheila I.
    Motukupally, Swapna R.
    Jain, Mitesh
    CORNEA, 2014, 33 (09) : 923 - 927
  • [8] Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
    Karagoz, Gul
    Kadanali, Ayten
    Dede, Behiye
    Sahin, Omer Torun
    Comoglu, Senol
    Altug, Sevda Babacan
    Naderi, Sait
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (01) : 93 - 94
  • [9] Cefiderocol and Intraventricular Colistin for Ventriculitis due to an Extensively Drug-Resistant Pseudomonas Aeruginosa
    Silva, Joao Melo e
    Oliveira, Diogo
    Louro, Joao A.
    Monteiro, Elisabete
    JOURNAL OF CRITICAL CARE MEDICINE, 2024, 10 (02): : 183 - 187
  • [10] Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa
    Xipell, Marc
    Bodro, Marta
    Marco, Francesc
    Losno, Ricardo A.
    Cardozo, Celia
    Soriano, Alex
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (02) : 266 - 268
12345